The Effect of Training and Follow-up Given to Cancer Patients Receiving Chemotherapy According to the Neuman Systems Model on the Development of Oral Mucositis and Perceptions of Comfort in Patients
Launched by ATATURK UNIVERSITY · Aug 6, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how training and follow-up support can help cancer patients receiving chemotherapy in managing a painful condition called oral mucositis, which is inflammation and soreness in the mouth. The goal is to see if providing education and resources based on a specific care model can prevent this condition or lessen its severity, ultimately improving comfort for patients during their treatment.
To participate in this trial, you should be an adult currently receiving chemotherapy that can cause oral mucositis, such as certain drugs like methotrexate or cisplatin. You also need to have access to the internet, be able to use a smartphone, and have at least a primary education level. Participants can expect to receive helpful training and follow-up throughout the study to support their health during treatment. If you are interested in helping improve care for cancer patients and meet the eligibility criteria, you may want to consider joining this important research effort.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Receiving chemotherapy treatment No mental or communication problems, Volunteering to participate in research. having internet, Having at least primary education level, Being able to use smart phone and internet. Being on treatment that causes methotrexate, Cispilatin, Cyclophoshamide, 5-fluorouracil group oral mucositis.
- • -
- Exclusion Criteria:
- • lack of internet illiteracy
- • -
About Ataturk University
Atatürk University, located in Erzurum, Turkey, is a prominent academic institution dedicated to advancing research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative medical research aimed at improving patient outcomes and contributing to the global body of health knowledge. Committed to ethical standards and rigorous scientific methodologies, Atatürk University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of its clinical trials, ultimately enhancing the quality of care and driving advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erzurum, Center, Turkey
Patients applied
Trial Officials
Gülcan B.TURAN
Principal Investigator
Firat University
Yasemin Erdem
Principal Investigator
Erzurum Technical University
Seda Karaman
Principal Investigator
Atatatürk Üniversitesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported